June 5, 2026 08:55 AM EDT News Briefing Fulcrum lays off majority of staff; Seres extends runway into 2027 Kyle LaHucik Biotech Correspondent 👥 Fulcrum Therapeutics reduced to a shell: The biotech is letting go 48 of its 57 full-time employees, according to an SEC Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
79 words · extracted 1mo agoread original ↗
comments(0)
5-min edit window · permanent after that